Serum osteoprotegerin and serum RANKL in Paget's disease.

被引：0
|
作者：
Nuti, R [1 ]
Martini, G [1 ]
Valenti, R [1 ]
Giovani, S [1 ]
Gennari, L [1 ]
Salvadori, S [1 ]
Galli, B [1 ]
机构：
[1] Univ Siena, Metab Dis Unit, I-53100 Siena, Italy
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SA404
引用
收藏
页码：S280 / S280
页数：1
相关论文
共 50 条
  • [1] Serum osteoprotegerin and receptor activator nuclear factor ligand (RANKL) in Paget's disease of bone.
    Alvarez, L
    Guañabens, N
    Peris, P
    Ros, I
    Ferró, T
    Pons, F
    Filella, X
    Monegal, A
    Muñoz-Gomez, J
    Ballesta, AM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S380 - S380
  • [2] The effect of zoledronic acid on serum Dickkopf-1, osteoprotegerin and rankl in patients with paget's disease of bone
    Polyzos, S. A.
    Anastasilakis, A. D.
    Efstathiadou, Z.
    Kita, M.
    Litsas, I.
    Avramidis, A.
    Arsos, G.
    Moralidis, E.
    Gerou, S.
    Pavlidou, V.
    Papatheodorou, A.
    Terpos, E.
    [J]. BONE, 2009, 44 (02) : S289 - S289
  • [3] The Effect of Zoledronic Acid on Serum Dickkopf-1, Osteoprotegerin, and RANKL in Patients with Paget's Disease of Bone
    Polyzos, S. A.
    Anastasilakis, A. D.
    Efstathiadou, Z.
    Kita, M.
    Litsas, I.
    Avramidis, A.
    Arsos, G.
    Moralidis, E.
    Gerou, S.
    Pavlidou, V.
    Papatheodorou, A.
    Terpos, E.
    [J]. HORMONE AND METABOLIC RESEARCH, 2009, 41 (11) : 846 - 850
  • [4] Osteoprotegerin deficiency and juvenile Paget's disease.
    Hofbauer, LC
    Schoppet, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20): : 1622 - 1622
  • [5] Serum osteoprotegerin and rankl levels in chronic alcoholic liver disease
    García-Valdecasas-Campelo, E
    González-Reimers, E
    Santolaria-Fernández, F
    De La Vega-Prieto, MJ
    Milena-Abril, A
    Sánchez-Pérez, MJ
    Martínez-Riera, A
    Gomez-Rodriguez, MD
    [J]. ALCOHOL AND ALCOHOLISM, 2006, 41 (03): : 261 - 266
  • [6] Truncation of osteoprotegerin in an isolated case of Juvenile Paget's disease.
    Janssens, K
    de Vernejoul, M
    De Freitas, F
    Van Hul, W
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S390 - S390
  • [7] Serum osteoprotegerin as a novel marker of metabolic bone disease.
    Hannan, FM
    Fairney, A
    Kyd, R
    Patel, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S129 - S129
  • [8] A comparison of serum and urine bone resorption markers in patients with Paget's disease.
    Naylor, KE
    Bainbridge, P
    Eastell, R
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S541 - S541
  • [9] Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
    Anna Wasilewska
    Agnieszka Rybi-Szuminska
    Walentyna Zoch-Zwierz
    [J]. Pediatric Nephrology, 2010, 25 : 2067 - 2075
  • [10] Serum osteoprotegerin and its ligand in Paget's disease of bone -: Relationship to disease activity and effect of treatment with bisphosphonates
    Alvarez, L
    Peris, P
    Guañabens, N
    Vidal, S
    Ros, I
    Pons, F
    Filella, X
    Monegal, A
    Muñoz-Gomez, J
    Ballesta, AM
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (03): : 824 - 828
12345